Quick Answer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. reported Cash and Equivalents of $63.71 million for fiscal year 2025.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $63.71M | +15.1% |
| 2024 | $55.37M | -69.2% |
| 2023 | $179.91M | -44.7% |
| 2022 | $325.09M | -29.4% |
| 2021 | $460.73M | +464.5% |
| 2020 | $81.61M | +175.5% |
| 2019 | $29.63M | +57.2% |
| 2018 | $18.84M | +14.2% |
| 2017 | $16.51M | -1.5% |
| 2016 | $16.77M | -50.1% |
| 2015 | $33.63M | -7.7% |
| 2014 | $36.45M | +38.3% |
| 2013 | $26.36M | -43.4% |
| 2012 | $46.54M | -20.9% |
| 2011 | $58.87M | -60.1% |
| 2010 | $147.65M | +65.5% |
| 2009 | $89.23M | +13.7% |
| 2008 | $78.46M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $56.47M | -27.6% | +3.0% |
| June 30, 2025 | $54.80M | -44.9% | -6.3% |
| March 31, 2025 | $58.51M | -23.7% | +5.7% |
| December 31, 2024 | $55.37M | -69.2% | -29.0% |
| September 30, 2024 | $77.98M | -79.8% | -21.6% |
| June 30, 2024 | $99.53M | -52.4% | +29.9% |
| March 31, 2024 | $76.65M | -78.3% | -57.4% |
| December 31, 2023 | $179.91M | -44.7% | -53.3% |
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. showed an increase of +15.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.’s cash and equivalents has declined by 18.8% (from $78.46 million to $63.71 million).
- The most recent figure is from PACIFIC BIOSCIENCES OF CALIFORNIA, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: